These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
132 related articles for article (PubMed ID: 37506604)
1. Neurophysiological correlates of non-motor symptoms in late premanifest and early-stage manifest huntington's disease. Davis MC; Hill AT; Fitzgerald PB; Bailey NW; Stout JC; Hoy KE Clin Neurophysiol; 2023 Sep; 153():166-176. PubMed ID: 37506604 [TBL] [Abstract][Full Text] [Related]
2. Effects of medial prefrontal transcranial alternating current stimulation on neural activity and connectivity in people with Huntington's disease and neurotypical controls. Davis MC; Fitzgerald PB; Bailey NW; Sullivan C; Stout JC; Hill AT; Hoy KE Brain Res; 2023 Jul; 1811():148379. PubMed ID: 37121424 [TBL] [Abstract][Full Text] [Related]
3. EEG Functional Connectivity and Cognitive Variables in Premanifest and Manifest Huntington's Disease: EEG Low-Resolution Brain Electromagnetic Tomography (LORETA) Study. Delussi M; Nazzaro V; Ricci K; de Tommaso M Front Physiol; 2020; 11():612325. PubMed ID: 33391027 [TBL] [Abstract][Full Text] [Related]
4. Differential Changes in Functional Connectivity of Striatum-Prefrontal and Striatum-Motor Circuits in Premanifest Huntington's Disease. Kronenbuerger M; Hua J; Bang JYA; Ultz KE; Miao X; Zhang X; Pekar JJ; van Zijl PCM; Duan W; Margolis RL; Ross CA Neurodegener Dis; 2019; 19(2):78-87. PubMed ID: 31412344 [TBL] [Abstract][Full Text] [Related]
5. Potential endpoints for clinical trials in premanifest and early Huntington's disease in the TRACK-HD study: analysis of 24 month observational data. Tabrizi SJ; Reilmann R; Roos RA; Durr A; Leavitt B; Owen G; Jones R; Johnson H; Craufurd D; Hicks SL; Kennard C; Landwehrmeyer B; Stout JC; Borowsky B; Scahill RI; Frost C; Langbehn DR; Lancet Neurol; 2012 Jan; 11(1):42-53. PubMed ID: 22137354 [TBL] [Abstract][Full Text] [Related]
6. Quantitative Electroencephalographic Analysis Provides an Early-Stage Indicator of Disease Onset and Progression in the zQ175 Knock-In Mouse Model of Huntington's Disease. Fisher SP; Schwartz MD; Wurts-Black S; Thomas AM; Chen TM; Miller MA; Palmerston JB; Kilduff TS; Morairty SR Sleep; 2016 Feb; 39(2):379-91. PubMed ID: 26446107 [TBL] [Abstract][Full Text] [Related]
7. Motivationally salient cue processing measured using the monetary incentive delay (MID) task with electroencephalography (EEG): A potential marker of apathy in Huntington's disease. Davis MC; Hill AT; Fitzgerald PB; Stout JC; Hoy KE Neuropsychologia; 2022 Dec; 177():108426. PubMed ID: 36414099 [TBL] [Abstract][Full Text] [Related]
8. Neuropsychiatric symptoms are very common in premanifest and early stage Huntington's Disease. Martinez-Horta S; Perez-Perez J; van Duijn E; Fernandez-Bobadilla R; Carceller M; Pagonabarraga J; Pascual-Sedano B; Campolongo A; Ruiz-Idiago J; Sampedro F; Landwehrmeyer GB; ; Kulisevsky J Parkinsonism Relat Disord; 2016 Apr; 25():58-64. PubMed ID: 26898966 [TBL] [Abstract][Full Text] [Related]
13. Abnormal Electrophysiological Motor Responses in Huntington's Disease: Evidence of Premanifest Compensation. Turner LM; Croft RJ; Churchyard A; Looi JC; Apthorp D; Georgiou-Karistianis N PLoS One; 2015; 10(9):e0138563. PubMed ID: 26406226 [TBL] [Abstract][Full Text] [Related]
14. Predictors of Working Capacity Changes Related to Huntington's Disease: A Longitudinal Study. van der Zwaan KF; Jacobs M; van Zwet EW; Roos RAC; de Bot ST J Huntingtons Dis; 2021; 10(2):269-276. PubMed ID: 33523014 [TBL] [Abstract][Full Text] [Related]
15. Predictors of phenotypic progression and disease onset in premanifest and early-stage Huntington's disease in the TRACK-HD study: analysis of 36-month observational data. Tabrizi SJ; Scahill RI; Owen G; Durr A; Leavitt BR; Roos RA; Borowsky B; Landwehrmeyer B; Frost C; Johnson H; Craufurd D; Reilmann R; Stout JC; Langbehn DR; Lancet Neurol; 2013 Jul; 12(7):637-49. PubMed ID: 23664844 [TBL] [Abstract][Full Text] [Related]